The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants
Ning Wang,
Xu Han,
Shengpu Hao,
Jingzhe Han,
Xiaomeng Zhou,
Shuyan Sun,
Jin Tang,
Yanpeng Lu,
Hongran Wu,
Shaojuan Ma,
Xueqin Song,
Guang Ji
Affiliations
Ning Wang
Department of Neurology, The Second Hospital of Hebei Medical University
Xu Han
Department of Neurology, The Second Hospital of Hebei Medical University
Shengpu Hao
Department of Neurology, The Second Hospital of Hebei Medical University
Jingzhe Han
Department of Neurology, The Second Hospital of Hebei Medical University
Xiaomeng Zhou
MyGenosticsInc
Shuyan Sun
Department of Neurology, The Second Hospital of Hebei Medical University
Jin Tang
Department of Neurology, The Second Hospital of Hebei Medical University
Yanpeng Lu
Department of Neurology, The Second Hospital of Hebei Medical University
Hongran Wu
Department of Neurology, The Second Hospital of Hebei Medical University
Shaojuan Ma
Department of Neurology, The Second Hospital of Hebei Medical University
Xueqin Song
Department of Neurology, The Second Hospital of Hebei Medical University
Guang Ji
Department of Neurology, The Second Hospital of Hebei Medical University
Abstract Background Dysferlinopathy is an autosomal recessive muscular dystrophy caused by pathogenic variants in the dysferlin (DYSF) gene. This disease shows heterogeneous clinical phenotypes and genetic characteristics. Methods We reviewed the clinical and pathological data as well as the molecular characteristics of 26 Chinese patients with dysferlinopathy screened by immunohistochemistry staining and pathogenic variants in DYSF genes. Results Among 26 patients with dysferlinopathy, 18 patients (69.2%) presented as Limb-girdle Muscular Dystrophy Type R2 (LGMD R2), 4 (15.4%) had a phenotype of Miyoshi myopathy (MM), and 4 (15.4%) presented as asymptomatic hyperCKemia. Fifteen patients (57.7%) were originally misdiagnosed as inflammatory myopathy or other diseases. Fifteen novel variants were identified among the 40 variant sites identified in this cohort. Conclusion Dysferlinopathy is a clinically and genetically heterogeneous group of disorders with various phenotypes, a high proportion of novel variants, and a high rate of misdiagnosis before immunohistochemistry staining and genetic analysis.